Logo image of HOPE

HOPE BANCORP INC (HOPE) Stock Fundamental Analysis

NASDAQ:HOPE - US43940T1097 - Common Stock

11.05 USD
+0.05 (+0.45%)
Last: 8/26/2025, 8:00:01 PM
11.05 USD
0 (0%)
After Hours: 8/26/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to HOPE. HOPE was compared to 393 industry peers in the Banks industry. HOPE may be in some trouble as it scores bad on both profitability and health. HOPE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

HOPE had positive earnings in the past year.
HOPE had a positive operating cash flow in the past year.
Each year in the past 5 years HOPE has been profitable.
Each year in the past 5 years HOPE had a positive operating cash flow.
HOPE Yearly Net Income VS EBIT VS OCF VS FCFHOPE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

HOPE's Return On Assets of 0.22% is on the low side compared to the rest of the industry. HOPE is outperformed by 86.26% of its industry peers.
HOPE has a Return On Equity of 1.88%. This is amonst the worse of the industry: HOPE underperforms 86.77% of its industry peers.
Industry RankSector Rank
ROA 0.22%
ROE 1.88%
ROIC N/A
ROA(3y)0.81%
ROA(5y)0.84%
ROE(3y)7.26%
ROE(5y)7.4%
ROIC(3y)N/A
ROIC(5y)N/A
HOPE Yearly ROA, ROE, ROICHOPE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of HOPE (9.36%) is worse than 83.97% of its industry peers.
HOPE's Profit Margin has declined in the last couple of years.
The Operating Margin and Gross Margin are not available for HOPE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 9.36%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-17.06%
PM growth 5Y-8.73%
GM growth 3YN/A
GM growth 5YN/A
HOPE Yearly Profit, Operating, Gross MarginsHOPE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

HOPE does not have a ROIC to compare to the WACC, probably because it is not profitable.
HOPE has more shares outstanding than it did 1 year ago.
The number of shares outstanding for HOPE has been reduced compared to 5 years ago.
Compared to 1 year ago, HOPE has a worse debt to assets ratio.
HOPE Yearly Shares OutstandingHOPE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
HOPE Yearly Total Debt VS Total AssetsHOPE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

The Debt to FCF ratio of HOPE is 0.80, which is an excellent value as it means it would take HOPE, only 0.80 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 0.80, HOPE is doing good in the industry, outperforming 77.86% of the companies in the same industry.
HOPE has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.05, HOPE belongs to the best of the industry, outperforming 81.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.8
Altman-Z N/A
ROIC/WACCN/A
WACC23.16%
HOPE Yearly LT Debt VS Equity VS FCFHOPE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
HOPE Yearly Current Assets VS Current LiabilitesHOPE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

4

3. Growth

3.1 Past

HOPE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.96%.
The Earnings Per Share has been decreasing by -8.76% on average over the past years.
HOPE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.16%.
The Revenue has been decreasing by -1.66% on average over the past years.
EPS 1Y (TTM)-15.96%
EPS 3Y-19.52%
EPS 5Y-8.76%
EPS Q2Q%-13.64%
Revenue 1Y (TTM)-14.16%
Revenue growth 3Y-5.14%
Revenue growth 5Y-1.66%
Sales Q2Q%-19.12%

3.2 Future

HOPE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.49% yearly.
Based on estimates for the next years, HOPE will show a quite strong growth in Revenue. The Revenue will grow by 11.35% on average per year.
EPS Next Y8.23%
EPS Next 2Y20.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.95%
Revenue Next 2Y11.35%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
HOPE Yearly Revenue VS EstimatesHOPE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M
HOPE Yearly EPS VS EstimatesHOPE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 13.99 indicates a correct valuation of HOPE.
HOPE's Price/Earnings ratio is a bit more expensive when compared to the industry. HOPE is more expensive than 60.31% of the companies in the same industry.
HOPE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 8.85, the valuation of HOPE can be described as reasonable.
74.81% of the companies in the same industry are more expensive than HOPE, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.67, HOPE is valued rather cheaply.
Industry RankSector Rank
PE 13.99
Fwd PE 8.85
HOPE Price Earnings VS Forward Price EarningsHOPE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of HOPE indicates a somewhat cheap valuation: HOPE is cheaper than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.23
EV/EBITDA N/A
HOPE Per share dataHOPE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as HOPE's earnings are expected to grow with 20.49% in the coming years.
PEG (NY)1.7
PEG (5Y)N/A
EPS Next 2Y20.49%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 5.37%, HOPE is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.30, HOPE pays a better dividend. On top of this HOPE pays more dividend than 90.08% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, HOPE pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.37%

5.2 History

HOPE has paid a dividend for at least 10 years, which is a reliable track record.
HOPE has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)0%
Div Incr Years0
Div Non Decr Years12
HOPE Yearly Dividends per shareHOPE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

HOPE pays out 164.57% of its income as dividend. This is not a sustainable payout ratio.
DP164.57%
EPS Next 2Y20.49%
EPS Next 3YN/A
HOPE Yearly Income VS Free CF VS DividendHOPE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
HOPE Dividend Payout.HOPE Dividend Payout, showing the Payout Ratio.HOPE Dividend Payout.PayoutRetained Earnings

HOPE BANCORP INC

NASDAQ:HOPE (8/26/2025, 8:00:01 PM)

After market: 11.05 0 (0%)

11.05

+0.05 (+0.45%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-27 2025-10-27/bmo
Inst Owners87.06%
Inst Owner Change4.7%
Ins Owners4.59%
Ins Owner Change8.62%
Market Cap1.42B
Analysts76
Price Target12.5 (13.12%)
Short Float %2.14%
Short Ratio2.69
Dividend
Industry RankSector Rank
Dividend Yield 5.37%
Yearly Dividend0.56
Dividend Growth(5Y)0%
DP164.57%
Div Incr Years0
Div Non Decr Years12
Ex-Date08-01 2025-08-01 (0.14)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-5.44%
Min EPS beat(2)-10.23%
Max EPS beat(2)-0.65%
EPS beat(4)1
Avg EPS beat(4)-0.36%
Min EPS beat(4)-10.23%
Max EPS beat(4)14.13%
EPS beat(8)2
Avg EPS beat(8)-1.47%
EPS beat(12)3
Avg EPS beat(12)-2.48%
EPS beat(16)7
Avg EPS beat(16)0.31%
Revenue beat(2)0
Avg Revenue beat(2)-15.7%
Min Revenue beat(2)-30.75%
Max Revenue beat(2)-0.65%
Revenue beat(4)0
Avg Revenue beat(4)-10.15%
Min Revenue beat(4)-30.75%
Max Revenue beat(4)-0.65%
Revenue beat(8)1
Avg Revenue beat(8)-6.96%
Revenue beat(12)2
Avg Revenue beat(12)-6.64%
Revenue beat(16)4
Avg Revenue beat(16)-4.95%
PT rev (1m)0%
PT rev (3m)3.16%
EPS NQ rev (1m)-3.1%
EPS NQ rev (3m)-3.74%
EPS NY rev (1m)-4.95%
EPS NY rev (3m)0.27%
Revenue NQ rev (1m)-1.56%
Revenue NQ rev (3m)0.47%
Revenue NY rev (1m)-1.29%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE 13.99
Fwd PE 8.85
P/S 3.18
P/FCF 10.23
P/OCF 9.52
P/B 0.64
P/tB 0.83
EV/EBITDA N/A
EPS(TTM)0.79
EY7.15%
EPS(NY)1.25
Fwd EY11.3%
FCF(TTM)1.08
FCFY9.77%
OCF(TTM)1.16
OCFY10.5%
SpS3.48
BVpS17.35
TBVpS13.25
PEG (NY)1.7
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.22%
ROE 1.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 9.36%
GM N/A
FCFM 31.05%
ROA(3y)0.81%
ROA(5y)0.84%
ROE(3y)7.26%
ROE(5y)7.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-17.06%
PM growth 5Y-8.73%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.8
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 2.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 331.83%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC23.16%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.94%
Cap/Sales(5y)1.61%
Profit Quality(3y)223.38%
Profit Quality(5y)193.88%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.96%
EPS 3Y-19.52%
EPS 5Y-8.76%
EPS Q2Q%-13.64%
EPS Next Y8.23%
EPS Next 2Y20.49%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.16%
Revenue growth 3Y-5.14%
Revenue growth 5Y-1.66%
Sales Q2Q%-19.12%
Revenue Next Year10.95%
Revenue Next 2Y11.35%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.16%
FCF growth 3Y-30.39%
FCF growth 5Y-9.62%
OCF growth 1Y-64.7%
OCF growth 3Y-28.86%
OCF growth 5Y-8.69%